Wissenschaftliche Arbeiten

Prof. Dr. Leylagül Kaynar

572 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Retrospective evaluation of patients with primary mediastinal large B-Cell lymphoma: Real life experience

    Annals of Medical Research, 2021

    DOI 10.5455/annalsmedres.2020.10.1026 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/s2152-2650(21)01484-1 Quelle: OpenAlex

  3. İnvaziv Duktal Meme Karsinomu Tedavisi Sonrası Gelişen Akut Myeloid Lösemi

    LLM Dergi, 2021

    DOI 10.5578/llm.20219603 Quelle: OpenAlex

  4. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

    Kocaeli Üniversitesi - AVESİS, 2021

    Quelle: OpenAlex

  5. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

    Annals of Hematology, 2020

    DOI 10.1007/s00277-020-04077-4 PMID 32507911 17 Zitationen (Europe PMC) Quelle: OpenAlex

  6. Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

    Frontiers in Immunology, 2020

    DOI 10.3389/fimmu.2020.00586 PMID 32351502 20 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  7. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/j.clml.2020.02.017 PMID 32482539 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

    Journal of clinical lipidology, 2020

    DOI 10.1016/j.jacl.2020.04.006 PMID 32423761 8 Zitationen (Europe PMC) Quelle: OpenAlex

  9. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/j.clml.2020.05.009 PMID 32605899 4 Zitationen (Europe PMC) Quelle: OpenAlex

  10. The Outcome of Fungal Pneumonia with Hematological Cancer

    Infection and Chemotherapy, 2020

    DOI 10.3947/ic.2020.52.4.530 PMID 33377321 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  11. İmmün Yetmezlikli Hastalardan Elde Edilen Sitomegalovirüs İzolatlarındaki Gansiklovir Direncinin Araştırılması

    Mikrobiyoloji Bulteni, 2020

    DOI 10.5578/mb.70062 PMID 33107291 3 Zitationen (Europe PMC) Quelle: OpenAlex

  12. Chemotherapy-induced Toxic Leukoencephalopathy

    Turkish Journal Of Neurology, 2020

    DOI 10.4274/tnd.2019.12369 Quelle: OpenAlex

  13. Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102844 PMID 32586769 5 Zitationen (Europe PMC) Quelle: OpenAlex

  14. Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.112 Quelle: OpenAlex

  15. Remisyon İndüksiyon Kemoterapisinde Posakonazol Proflaksisi Ne Zaman Başlanmalı

    DergiPark (Istanbul University), 2020

    Quelle: OpenAlex

  16. İyileştirme ve Geliştirme Süreci

    Turkiye Klinikleri Hematology - Special Topics, 2020

    Quelle: OpenAlex

  17. BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE

    AYBU AVESIS, 2020

    Quelle: OpenAlex

  18. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

    Journal of clinical lipidology, 2019

    DOI 10.1016/j.jacl.2019.02.001 PMID 30928440 33 Zitationen (Europe PMC) Quelle: OpenAlex

  19. Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party

    Haematologica, 2019

    DOI 10.3324/haematol.2019.228668 PMID 31601686 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience

    Annals of Hematology, 2019

    DOI 10.1007/s00277-019-03899-1 PMID 31844933 6 Zitationen (Europe PMC) Quelle: OpenAlex

  21. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable ≥Vgpr Responses Among Immunomodulatory / Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

    Clinical Lymphoma Myeloma & Leukemia, 2019

    DOI 10.1016/j.clml.2019.09.402 2 Zitationen (OpenAlex) Quelle: OpenAlex

  22. Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study

    Turkish Journal of Hematology, 2019

    DOI 10.4274/tjh.galenos.2019.2019.0008 PMID 31131598 Frei zugänglicher VolltextQuelle: OpenAlex

  23. The Importance of CMV PCR Monitoring in Hematologic Malignant Patients Take Chemotherapy

    LLM Dergi, 2019

    DOI 10.5578/llm.68984 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000563260.18006.d6 Frei zugänglicher VolltextQuelle: OpenAlex

  25. PB1688 SUCCESSFUL HAPLOIDENTIC BONE MARROW TRANSPLANTATION WITH INOTUZUMAB OZOGAMICIN IN PATIENT WITH RELAPSED AND RESISTANT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000565268.92117.90 Frei zugänglicher VolltextQuelle: OpenAlex

  26. Herediter anjioödemde kısa dönem danazol profilaksisi ile implant tedavisi: Vaka raporu

    Selcuk Dental Journal, 2019

    DOI 10.15311/selcukdentj.384245 Quelle: OpenAlex

  27. Kronik Graft Versus Host Hastalığı: Kurtarma Tedavileri

    Turkiye Klinikleri Hematology - Special Topics, 2019

    Quelle: OpenAlex

  28. Kronik Graft Versus Host Hastalığı

    2019

    Quelle: OpenAlex

  29. Gastrointestinal plasmoblastic lymphoma associated with Wiskott-Aldrich syndrome: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30311-x Quelle: OpenAlex

  30. Successful treatment of relapsed and refractory cold agglutinin disease with bortezomib: case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30375-3 Quelle: OpenAlex

  31. Risk factors for invasive fungal infection in patients who underwent allogeneic hematopoietic stem cell transplantation

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30351-0 Quelle: OpenAlex

  32. Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30293-0 Quelle: OpenAlex

  33. Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

    Blood, 2019

    DOI 10.1182/blood-2019-123387 Quelle: OpenAlex

  34. Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data

    Blood, 2019

    DOI 10.1182/blood-2019-126006 Quelle: OpenAlex

  35. Chronic Graft Versus Host Disease

    2019

    Quelle: OpenAlex

  36. Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  37. Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  38. Cytokine release syndrome

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.09.002 Quelle: OpenAlex

  39. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries

    Journal of Hospital Infection, 2018

    DOI 10.1016/j.jhin.2018.07.022 PMID 30036635 19 Zitationen (Europe PMC) Quelle: OpenAlex

  40. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

    Atherosclerosis, 2018

    DOI 10.1016/j.atherosclerosis.2018.01.034 PMID 29407887 32 Zitationen (Europe PMC) Quelle: OpenAlex

  41. Outcomes for haematological cancer patients admitted to an intensive care unit in a university hospital

    Australian Critical Care, 2018

    DOI 10.1016/j.aucc.2017.10.005 PMID 29429570 13 Zitationen (Europe PMC) Quelle: OpenAlex

  42. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

    Hematology, 2018

    DOI 10.1080/10245332.2018.1498167 PMID 29996726 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  43. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

    Transfusion and Apheresis Science, 2018

    DOI 10.1016/j.transci.2018.02.012 PMID 29503132 7 Zitationen (Europe PMC) Quelle: OpenAlex

  44. Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patients

    Journal of Clinical Practice and Research, 2018

    DOI 10.5152/etd.2017.0118 Quelle: OpenAlex

  45. Response to the Letter to the Editor: Critically ill Haematological Cancer Patients: How far the Severity Index Score can determine the outcome and duration of Aggressive Support?

    Australian Critical Care, 2018

    DOI 10.1016/j.aucc.2018.07.002 PMID 30415912 Quelle: OpenAlex

  46. The Comparison of Melphalan Administration on Day −3 With Administration on Day −1 on Neutrophil and Platelet Engraftment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

    Journal of Global Oncology, 2018

    DOI 10.1200/jgo.18.88300 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  47. The Comparison of Melphalan Administration on Day 3 with Administration on Day 1 on Neutrophil and Platelet Engraftment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

    Blood, 2018

    DOI 10.1182/blood-2018-99-115353 1 Zitation (OpenAlex) Quelle: OpenAlex

  48. Hiperlipidemi Tedavisinde Terapötik Aferez

    Turkiye Klinikleri Endocrinology - Special Topics, 2018

    Quelle: OpenAlex

  49. Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patient

    Journal of Clinical Practice and Research, 2018

    DOI 10.5152/etd.2018.18118 Quelle: OpenAlex

  50. Successful Treatment With Granulocyte Transfusion and Early Neutrophil Engraftment in Allogeneic Transplant Patients With Febrile Neutropenia: Does Granulocyte Transfusion Effect on Neutrophil Engraftment?

    Journal of Global Oncology, 2018

    DOI 10.1200/jgo.18.91100 Frei zugänglicher VolltextQuelle: OpenAlex